UNSPSC 51263114: Bunitrolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F2613LO055, chemically known as 2-propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)- but generally known as bunitrolol, which bears US NIH Compound Identifier 2473. Bunitrolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bunitrolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05978MIG.

UNSPSC 51263114 Bunitrolol (Commodity) is a pharmaceutical product code that appears to see limited recent state and local procurement activity under its nominal classification. The most recent opportunity on file reflects a significant mismatch: Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure Naloxone and Safe Drug Deactivation Systems, not bunitrolol. The county is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their proposals, submit bids electronically through the county's e-Procurement Portal, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with a one-year renewal option, and the county reserves the right to terminate during a three-month probationary period with or without cause. The procurement may be FEMA-funded, which subjects vendors to additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The source provides no evidence of substantial recent state and local procurement activity under UNSPSC 51263114 for bunitrolol itself. The single tagged opportunity — Seminole County's naloxone and drug-deactivation-systems procurement — lies outside the code's nominal pharmaceutical scope. State and local procurement professionals evaluating this code should verify current classification accuracy and monitor for updates to the underlying opportunities database, as the tagged opportunity suggests either a coding error or a significant divergence between the UNSPSC category definition and actual buying patterns in this jurisdiction.